Overview

Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita

Status:
NOT_YET_RECRUITING

Trial end date:
2026-05-15

Target enrollment:

Participant gender:

Summary

The purpose of this clinical trial is to compare the efficacy and safety of emodepside, with the standard treatment, albendazole, in adolescents (12 years and older) and adults infected with Trichuris incognita.

Phase:

PHASE2

Details

Lead Sponsor:

Jennifer Keiser

Collaborators:

Bayer
Centre Suisse de Recherches Scientifiques en Cote d'Ivoire
Universit Flix Houphout-Boigny

Treatments:

Albendazole
emodepside